Diversified Trust’s Sarepta Therapeutics SRPT Stock Holding History

Diversified Trust’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$887K	Buy	+49,350	New	+$933K	0.01%	553

Other funds holding SRPT

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

QFA

Quattro Financial Advisors The Woodlands, Texas $468M AUM 13.49% 1-Year Est. Return

Diversified Trust's SRPT Position: Q2 2026 in Review

Diversified Trust opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 49,350 shares worth $887K. The stake represents 0.01% of the portfolio and ranks #553 among its holdings.

28 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Diversified Trust held 49,350 shares of Sarepta Therapeutics worth $887K as of Q2 2026.
Sarepta Therapeutics was a new Diversified Trust position in Q2 2026.
Sarepta Therapeutics made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #553 holding.
28 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.